The inventive features include recombinant mammalian E-selectin peptides, nucleic acids encoding said peptides, vectors and cells having these nucleic acids, and methods of making the peptides. Further inventive features include methods of treating diseases and conditions associated with inflammation using recombinant mammalian E-selectin peptides to induce mucosal tolerance to E-selectin.
申请公布号
WO2006099006(A3)
申请公布日期
2007.02.01
申请号
WO2006US08340
申请日期
2006.03.08
申请人
NOVAVAX, INC.;SMITH, GALE;PUSHKO, PETER;COICE, VITTORIA